| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
October 15, 2012 |
|
|
| |
|
|
| |
|
|
|
Center for Professional Innovation & Education, Inc., King of Prussia, PA
Jan 30 - Feb 1, 2013
Included in the course content is an overview of the regulatory and pre-marketing steps that occur to ensure a successful launch. The course also covers sales planning and the commercialization decisions that affect the development of the drug.
Topics include:
Basic concepts of drug discovery and testing
Scientific, regulatory, and management framework for modern pharmaceutical development
Pre-clinical study requirements and how information gathered is used for human clinical studies
The four major clinical phases (1-4) in the drug development process and the rationale for each and an introduction to the special problems of each phase
The economics of drug development
Cost/benefit issues in clinical development
Discovery and development milestones
The IND Process
The NDA Process
FDA Interactions – Application review and approval process
Patents and exclusivity
The rationale of government regulations and how they effect the development process
The relationship between the Code of Federal Regulations and ICH GCP
Designing optimal clinical trials
Drug labeling, marketing, and pharmacoeconomic studies
Project management cross functional teams during the development process
|
|
|
|
|
|
|
|
Organized by:
|
|
Center for Professional Innovation & Education, Inc. |
|
|
Invited Speakers:
|
|
Contact info@cfpie.com for a list of course instructors
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.cfpie.com/showitem.aspx?productid=025&source=hummolgen
|
|
|
E-mail:
|
|
info@cfpie.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|